Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Cystotech ApS
APS
Active
Advertising protection
CVR 42773565
Inge Lehmanns Gade 10, 8000
Aarhus C
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
16 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cystotech ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
AM
Anna Munk Nielsen
Management
Management
2025
CH
Claus Hansen
Management
Management
2024
Former (1)
JE
Jacob Elmose Jensen
Management
Management
2021 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
NM
Nazarena Mazzaro
Board of Directors
Board of Directors
2024
ON
Ole Niels Jakob Jensen
Board of Directors
Board of Directors
2022
JE
Jacob Elmose Jensen
Board of Directors
Board of Directors
2021
CH
Claus Hansen
Board of Directors
Board of Directors
2024
BH
Brian Hedegaard
Board of Directors
Board of Directors
2022
LC
Lars Christian Lund
Chairman
Chairman
2024
Former (1)
AM
Anna Munk Nielsen
Board of Directors
Board of Directors
2021 – 2022
Shareholders
Active legal owners
Cajbo ApS — 20–24.99%
Cloudbeam Holding ApS — 10–14.99%
Cystotech Invest ApS — 10–14.99%
Skovly-Munk Holding ApS — 10–14.99%
CH MEDINVEST ApS — 5–9.99%
Cystotech Invest II ApS — 5–9.99%
Den Midtjyske Iværksætterfond — 5–9.99%
h6capital ApS — 5–9.99%
INNOVATIONS A/S — 5–9.99%
75–100%
Shareholder
Type
Ownership
Votes
Since
Cajbo ApS
Company
20–24.99%
20–24.99%
2024
Cloudbeam Holding ApS
Company
10–14.99%
10–14.99%
2023
Cystotech Invest ApS
Company
10–14.99%
10–14.99%
2024
Skovly-Munk Holding ApS
Company
10–14.99%
10–14.99%
2023
CH MEDINVEST ApS
Company
5–9.99%
5–9.99%
2023
Cystotech Invest II ApS
Company
5–9.99%
5–9.99%
2025
Den Midtjyske Iværksætterfond
Company
5–9.99%
5–9.99%
2023
h6capital ApS
Company
5–9.99%
5–9.99%
2023
INNOVATIONS A/S
Company
5–9.99%
5–9.99%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Cystotech ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network